论文信息 - A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors - 字舞流文

A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors

J. Berlin | H. Wakelee | D. Rasco | D. Hong | P. Munster | T. George | A. Mita | I. Dimery | A. Balmanoukian | J. Luke | M. Gutierrez | M. Veeder | J. Chandler | E. Borazanci | S. Guan | T. Graef | S. Samakoglu